Is There A Place for Plasma Osteaopontin as Key Mediator in Patients With Diabetic Nephropathy?

Osteopontin As A Marker of Diabetic Nephropathy in Patients With Type 2 Diabetes Mellitus

Study of Plasma Copeptin as a Predictor of Diabetic Nephropathy in Type 2 Diabetic Patients

The Relationship between Serum Osteopontin level and Parameters of Chronic Kidney Disease – Mineral Bone Disease in Patients on Regular Hemodialysis

Plasma Osteopontin Level and Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus

Study The Association between Serum Osteoprotegerin and Diabetic Kidney Disease

The relation between serum osteoprotegerin level and coronary artery calcification in type 2 diabetes mellitus patients

Plasma Pentraxin-3 as a Predictor for Peripheral Arterial Disease in Maintenance Hemodialysis Egyptian Patients: A Single-Center Study

STUDY OF SERUM OSTEOINDUCTIVE FACTOR AS AN EARLY MARKER OF NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETIS

Serum Osteoinductive Factor as an early Marker of Nephropathy in Type 1 Diabetes Mellitus